Article Details

Theravance Biopharma, Inc. Initiates $250 Million Capital Return Program

Retrieved on: 2022-09-19 10:42:07

Tags for this article:

Click the tags to see associated articles and topics

Theravance Biopharma, Inc. Initiates $250 Million Capital Return Program. View article details on hiswai:

Excerpt

Examples of such statements include statements relating to: the referenced tender offer for Theravance Biopharma's ordinary shares and the referenced ...

Article found on: www.tullahomanews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up